AXIS
Clinicals goes global
v Starts largest CRO facility in Mexico spread
over 4000m2
v 100-bed facility with modern
bio-analytical & reference labs
Hyderabad, Jan. 15, 2013: AXIS Clinicals Group, a leading Clinical Research Organization (CRO) announces the commencement
of it’s operations at Mexico. With this facility, AXIS Clinicals Group now has
three centers spread in India & overseas and can offer clinical research solutions
to global clients.
This
new center is the largest CRO facility in Mexico with bio-analytical and
reference labs all housed in the same building that is spread over 4000 sq
meters. The Mexico center is a 100-bed clinical facility that can grow to
160-beds and has over 50 employees with eight doctors all recruited from
prestigious local universities. Over
300 methods have been developed on a global basis including hormonal, oncology
and biotechnological products. Separate ambulatory area and sampling area with
reclining reposers are also some of the key facilities at the centre.
It is the only CRO facility in
Northern Mexico City with a database of 5000 healthy volunteers, thus
minimizing risk of cross participation. It has received the COFEPRIS license
approval in record time and has four LCMS machines in its bio-analytical division
with a capacity to go up to 15 LCMS. The centre is equipped to handle phase II-IV
studies and has a database of 2000 investigators. It has already been contracted
for 75 studies from multinational, big pharma clientele as well as large local
Mexican laboratories. It is an active member of AMETA - Mexican CRO Industry Association.
About AXIS Clinicals
AXIS Clinicals Limited, one of India’s leading CRO is committed to serving the
biopharmaceutical industry by leveraging two
powerful trends impacting the world of Clinical Research - globalisation and
full spectrum offering.
Established in September 2004, the company has completed over 1500 clinical
studies, 300 ANDA studies and received 50 product approvals from regulatory
agencies. The company facilities have been accredited by DCGI (Drugs Controller
General, India), NABL (National Accreditation Board for Testing and Calibration
Laboratories - ISO 15189:2003) and inspected by US-FDA, UK-MHRA, Brazil-ANVISA
and France AFSSAPS and conforms to ICH and CDSCO-GCP & GLP Guidelines. For
further details, please visit – www.axisclinicals.com
